Craft

Futura Medical

Stock Price

£0.4

2024-10-29

Market Capitalization

£116.9 M

2024-10-29

Revenue

£1.7 M

FY, 2025

Futura Medical Summary

Company Summary

Overview
Futura's innovation strategy applies advanced science to develop products with compelling commercial potential using its advanced proprietary transdermal technology. Futura's development pipeline focuses on sexual healthcare and pain relief management and the company is evaluating further therapeutic opportunities as potential additions to the pipeline. Futura is gaining recognition within the pharmaceutical industry for its strengths in transdermal drug delivery technology. 
Type
Public
Status
Active
Founded
1997
HQ
Guildford, GB | view all locations
Website
https://futuramedical.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Ken James
  • Angela Hildreth

    Angela Hildreth, Finance Director, Chief Operating Officer and Company Secretary

  • Jeff Needham

    Jeff Needham, Non-Executive Chairman

    • Andrew Unitt

      Andrew Unitt, Senior Independent Non-Executive Director

    LocationsView all

    1 location detected

    • Guildford, England HQ

      United Kingdom

      Surrey Research Centre, 40 Occam Rd

    Futura Medical Financials

    Summary Financials

    Revenue (FY, 2025)
    £1.7M
    Gross profit (FY, 2025)
    £1.6M
    Net income (FY, 2025)
    (£9.1M)
    Cash (FY, 2025)
    £3.4M
    EBIT (FY, 2025)
    (£9.0M)

    Footer menu